Condition: Negative Symptoms of Schizophrenia · Sponsor: Minerva Neurosciences
Evaluate the efficacy, as well as safety and pharmacokinetics, of Roluperidone in improving the negative symptoms of schizophrenia in adult subjects in Phase A of study, followed by Phase B of study to evaluate the relapse rate of Roluperidone and antipsychotic medications.
This description comes directly from the study's public registry record.
Chief Operating Officer · 617-600-7373 · info@minervaneurosciences.com
Always discuss trial participation with your own doctor first.
| Clinical Innovations, Inc. dba CITrials | Bellflower, California, United States | Recruiting |
| ProScience Research Group | Culver City, California, United States | Recruiting |
| Collaborative Neuroscience Research, LLC | Garden Grove, California, United States | Recruiting |
| Clinical Innovations, Inc. dba CITrials | Riverside, California, United States | Recruiting |
| Velocity Clinical Research, Hallandale Beach | Hallandale, Florida, United States | Recruiting |
| Behavioral Clinical Research, Inc. | Hollywood, Florida, United States | Recruiting |
| ForCare Clinical Research | Tampa, Florida, United States | Recruiting |
| Atlanta Center for Medical Research, LLC | Atlanta, Georgia, United States | Recruiting |
| CenExel iResearch, LLC | Decatur, Georgia, United States | Recruiting |
| CBH Health, LLC dba CenExel | Gaithersburg, Maryland, United States | Recruiting |
| Hassman Research Institute, LLC dba CenExel | Marlton, New Jersey, United States | Recruiting |
| New York State Psychiatric Institute | New York, New York, United States | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07565428